Log in to save to my catalogue

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cel...

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cel...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2122528367

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies

About this item

Full title

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies

Publisher

United States: Public Library of Science

Journal title

PloS one, 2018-10, Vol.13 (10), p.e0205135-e0205135

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The objective of this study was to translate reaction conditions and quality control methods used for production of an astatine-211(211At)-labeled anti-CD45 monoclonal antibody (MAb) conjugate, 211At-BC8-B10, from the laboratory setting to cGMP production. Five separate materials were produced in the preparation of 211At-BC8-B10: (1) p-isothiocyana...

Alternative Titles

Full title

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2122528367

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2122528367

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0205135

How to access this item